United Therapeutics Stock News & Updates
[WKN: 923818 | Symbol: UTHR]Protect Your Portfolio With These 5 Safe US Stocks at all-Time Highs
United Therapeutics: TETON Breakthrough and EPS Beat Drive Record Rally
Clinical Milestone: The stock is shooting up on high volume after the TETON-1 study for Tyvaso in...
United Therapeutics: From Niche Player to Giant in Organ Technology
With the excellent study data from March 30, 2026, United Therapeutics is on the brink of tapping into...
United Therapeutics: TETON-1 Study for Idiopathic Pulmonary Fibrosis Offers Revenue Opportunity of $3.3 Billion!
United Therapeutics (UTHR) specializes in the treatment of rare lung diseases with its core product Tyvaso...
United Therapeutics (UTHR) in our Pivotal Point Check: Study Breakthrough in Pulmonary Fibrosis and $2 Billion Buyback Program Cause an all-Time High!
TETON-1 study exceeds expectations: The drug Tyvaso shows significant improvement in lung function...
Stocks in Action USA: Insmed, Alcoa, United Therapeutics
Insmed (INSM) – Biotech Stock Poised for Rebound: Analysts Fuel Momentum with 45% Price Potential!...
Buy-the-Dip Buyers Stop Wall Street Slide – Iran Conflict Drives Oil Price to $108 – Stagflation Risks Burden Markets – Week Ahead: All Eyes on the Labor Market – McDonald's Launches KPop Demon Hunters Menu - United Therapeutics Achieves Study Success - Aluminum World Market in Turmoil
USA & MACRO ENVIRONMENT Wall Street ends a turbulent phase with an initial counter-movement:...
United Therapeutics: TreSMI Shakes up the Rare Lung Disease Market
United Therapeutics (UTHR) is likely to maintain its trend for several reasons. With Tyvaso, the company...
United Therapeutics: Tyvaso Study Data Represents a new $5.4 Billion Opportunity – the Stock Reaches a new all-Time High!
United Therapeutics (UTHR) aims to reach a total revenue of $16 billion by 2030 through the treatment...
- ‹
- 1
- ›